Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting
Completed
Conditions studied: Cancer
In brief
1. To identify reasons for low patient recruitment numbers to clinical trials in a cancer research center setting (and a community setting) in order to attempt to increase accrual rates. 2. To review the screening sheet for women who considered participating in the study of Tamoxifen and Raloxifene (STAR) for the prevention of breast cancer in high risk women through the University of New Mexico in Albuquerque from 1999 through 2004
Key facts
- Study ID
- NCT00322647
- Run by
- University of New Mexico
- People needed
- 20
- Starts
- 2005-01-01
- Expected to finish
- 2007-06-01
- Last updated by the study team
- 2010-01-07
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women who considered participating in the study of Tamoxifen and Raloxifene (STAR) for the prevention of breast cancer in high risk women through the University of New Mexico in Albuquerque from 1999 through 2004
You may not qualify if…
- Not specified.
Where it is running
- University of New Mexico — Albuquerque, New Mexico, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.